Načítá se...
Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium
Chronic obstructive pulmonary disease (COPD) is a widespread respiratory disorder, usually characterized by progressive and poorly reversible airflow limitation. Inhaled long-acting bronchodilators, namely LABA (long-acting β(2)-adrenergic agonists) and LAMA (long-acting muscarinic receptor antagoni...
Uloženo v:
| Vydáno v: | Multidiscip Respir Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4333835/ https://ncbi.nlm.nih.gov/pubmed/25699181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2049-6958-9-64 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|